| Adherence to surgical care improvement project measures and the association with postoperative infections JJ Stulberg, CP Delaney, DV Neuhauser, DC Aron, P Fu, SM Koroukian Jama 303 (24), 2479-2485, 2010 | 600 | 2010 |
| Augmentation of umbilical cord blood (UCB) transplantation with ex vivo–expanded UCB cells: results of a phase 1 trial using the AastromReplicell System J Jaroscak, K Goltry, A Smith, B Waters-Pick, PL Martin, TA Driscoll, ... Blood 101 (12), 5061-5067, 2003 | 388 | 2003 |
| Activation of PI3K‐Akt signaling pathway promotes prostate cancer cell invasion S Shukla, GT MacLennan, DJ Hartman, P Fu, MI Resnick, S Gupta International journal of cancer 121 (7), 1424-1432, 2007 | 374 | 2007 |
| Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry JD Cramer, P Fu, KC Harth, S Margevicius, SM Wilhelm Surgery 148 (6), 1147-1153, 2010 | 354 | 2010 |
| Nuclear factor-κB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression S Shukla, GT MacLennan, P Fu, J Patel, SR Marengo, S Gupta Neoplasia 6 (4), 390-400, 2004 | 280 | 2004 |
| Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid P Savvides, G Nagaiah, P Lavertu, P Fu, JJ Wright, R Chapman, ... Thyroid 23 (5), 600-604, 2013 | 236 | 2013 |
| A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome CJ Mooney, G Nagaiah, P Fu, JK Wasman, MM Cooney, PS Savvides, ... Thyroid 19 (3), 233-240, 2009 | 228 | 2009 |
| The influence of chronic inflammation in prostatic carcinogenesis: a 5-year followup study GT MacLennan, R Eisenberg, RL Fleshman, JM Taylor, P Fu, MI Resnick, ... The Journal of urology 176 (3), 1012-1016, 2006 | 228 | 2006 |
| Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model S Gupta, VM Adhami, M Subbarayan, GT MacLennan, JS Lewin, ... Cancer research 64 (9), 3334-3343, 2004 | 219 | 2004 |
| Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients M Rahman, P Fu, AR Sehgal, MC Smith American journal of kidney diseases 35 (2), 257-265, 2000 | 211 | 2000 |
| Kangaroo Care modifies preterm infant heart rate variability in response to heel stick pain: pilot study X Cong, SM Ludington-Hoe, G McCain, P Fu Early human development 85 (9), 561-567, 2009 | 210 | 2009 |
| Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non–small cell lung cancer G Corredor, X Wang, Y Zhou, C Lu, P Fu, K Syrigos, DL Rimm, M Yang, ... Clinical cancer research 25 (5), 1526-1534, 2019 | 196 | 2019 |
| Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma S Gupta, T Hussain, GT MacLennan, P Fu, J Patel, H Mukhtar Journal of Clinical Oncology 21 (1), 106-112, 2003 | 194 | 2003 |
| Changes in CT radiomic features associated with lymphocyte distribution predict overall survival and response to immunotherapy in non–small cell lung cancer M Khorrami, P Prasanna, A Gupta, P Patil, PD Velu, R Thawani, ... Cancer immunology research 8 (1), 108-119, 2020 | 190 | 2020 |
| Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study M Pandey, P Kaur, S Shukla, A Abbas, P Fu, S Gupta Molecular carcinogenesis 51 (12), 952-962, 2012 | 187 | 2012 |
| Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway S Shukla, N Bhaskaran, MA Babcook, P Fu, GT MacLennan, S Gupta Carcinogenesis 35 (2), 452-460, 2014 | 180 | 2014 |
| Expansion of LTC-ICs and Maintenance of p21 and BCL-2 Expression in Cord Blood CD34+/CD38− Early Progenitors Cultured over Human MSCs as a Feeder … S Kadereit, LS Deeds, SE Haynesworth, ON Koc, MM Kozik, E Szekely, ... Stem Cells 20 (6), 573-582, 2002 | 173 | 2002 |
| Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications JS Bordeaux, KJ Martires, D Goldberg, SF Pattee, P Fu, ME Maloney Journal of the American Academy of Dermatology 65 (3), 576-583, 2011 | 171 | 2011 |
| Silicon phthalocyanine (Pc 4) photodynamic therapy is a safe modality for cutaneous neoplasms: results of a phase 1 clinical trial ED Baron, CL Malbasa, D Santo‐Domingo, P Fu, JD Miller, ... Lasers in surgery and medicine 42 (10), 888-895, 2010 | 169 | 2010 |
| Impairment of regulatory T-cell function in autoimmune thyroid disease AB Glick, A Wodzinski, P Fu, AD Levine, DN Wald Thyroid 23 (7), 871-878, 2013 | 166 | 2013 |
Anant MadabhushiDepartment of Biomedical Engineering, Professor, Biomedical Engineering, Emory Univ & Georgia TechGeverifieerd e-mailadres voor emory.edu
